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Background: The anxiety caused by the emergence of the novel coronavirus disease
(COVID-19) globally has made many Nigerians resort to self-medication for purported
protection against the disease, amid fear of contracting it from health workers and
hospital environments. Therefore, this study aimed to estimate the knowledge level,
causes, prevalence, and determinants of self-medication practices for the prevention
and/or treatment of COVID-19 in Nigeria.
Methods: A web-based cross-sectional survey was conducted between June and
July 2020 among the Nigerian population, using a self-reported questionnaire. Statistical
analysis of descriptive, bivariate, and multivariate analyses was done using STATA 15.
Results: A total of 461 respondents participated in the survey. Almost all the
respondents had sufficient knowledge about self-medication (96.7%). The overall
prevalence of self-medication for the prevention and treatment of COVID-19 was 41%.
The contributing factors were fear of stigmatization or discrimination (79.5%), fear of
being quarantine (77.3%), and fear of infection or contact with a suspected person
(76.3%). The proximal reasons for self-medication were emergency illness (49.1%),
delays in receiving hospital services (28.1%), distance to the health facility (23%), and
proximity of the pharmacy (21%). The most commonly used drugs for self-medication
were vitamin C and multivitamin (51.8%) and antimalarials (24.9%). These drugs were
boughtmainly from pharmacies (73.9%). From themultivariable logistic regressionmodel,
males (OR: 0.79; 95% CI: 0.07–0.54), and sufficient knowledge on SM (OR: 0.64; 95%
CI: 0.19–0.77) were significantly associated with self-medication.
Conclusion: The key finding of this study was the use of different over-the-counter
medications for the prevention (mainly vitamin C and multivitamins) and treatment
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(antibiotics/antimicrobial) of perceived COVID-19 infection by Nigerians with mainly
tertiary education. This is despite their high knowledge and risk associated with
self-medication. We suggest that medication outlets, media and community should be
engaged to support the rational use of medication.
Keywords: knowledge level, self-medication, COVID-19, determinants, Nigeria
INTRODUCTION
The index case of novel coronavirus disease (COVID-19) was
first described in Wuhan, China in December 2019 (1, 2). Since
then the disease has been reported in more than 215 countries
spread across the continents. About 120, 268, 427 confirmed cases
and 2, 659, 802 deaths were reported globally as of March 18,
2021 (2). It was declared a global pandemic by the World Health
Organization (WHO) onMarch 12, 2020 (3). COVAXCOVID-19
vaccines are now available inNigeria, though in limited quantities
that are available to health care and frontline workers in phase 1.
The pandemic is still a cause of concern because of inadequate
doses and negative perception of the vaccine by the general
population. In Nigeria, 161,737 confirmed cases of the disease
and 2,030 deaths were reported by the Nigeria Center for Disease
Control (NCDC) as of March 22, 2021 (4).
The disease created widespread anxiety and fear among the
population in sub-Saharan Africa (5), principally because of the
increase in confirmed cases in Africa as well as the high fatality
in America and Europe (3), worsened by the fact that there is no
approved vaccine or medication for its treatment. Consequent to
this, many people, especially those feeling unwell have resorted
to the consumption of different substances, including traditional
medicine to treat a perceived COVID-19 infection or to prevent
it, without considering the safety and efficacy of the substance to
the human body (6). The consumption or use of these substances
without expert advice from medical professionals is considered
as self-medication (SM). Self-medication is defined as the
consumption of medicines by individuals to treat self-recognized
illnesses or symptoms without consulting a physician (7–9).
Many Nigerians have resorted to SM since the outbreak of
COVID-19 in the country for purported protection against the
disease as a result of the fear of contracting it from health workers
and hospital environments, instead of accessing medical care
from physicians at the health facilities. Thus, many deaths due to
COVID-19 are linked to the practice of SM (10). Self-medication
may also impact on the health of individuals negatively by way
of toxicological and pharmacological risks associated with the
improper use of medicines (10). Nigeria already had a high
prevalence of SM before the COVID-19 pandemic, varying
between 52.1 and 92.3% (11–16). Babatunde et al. found that 51%
had ever practiced SM while 32% currently practiced SM among
health workers in a tertiary institution in South-West Nigeria
(12). Similarly, Ezeoke reported that two-thirds of undergraduate
students in a Nigerian University practiced self-medication (15)
while Oshikoya et al. found a similar rate of infants being
treated for colic without medical advice in Lagos, south-west
Nigeria (16). All these SM practices occur despite its documented
contribution to the emergence and spread of antimicrobial drug
resistance (12).
The sale of prescription drugs as over the counter (OTC)
drugs and the operation of too many unregistered patent
medicine stores/pharmacies without adequate check has been
a challenge (14, 17), and so the results from any study that
is aimed at evaluating self-medication practices and possible
factors associated with the practice, may be useful to the relevant
stakeholders and policymakers responsible for the management
of COVID-19 patients.
Therefore, our study aimed to evaluate the awareness of SM
in the context of COVID-19 in the Nigerian Population. An
additional aim was to estimate the prevalence of SM and its
determinants in the population.
METHODS
Study Design and Participants
A web-based cross-sectional survey was conducted between June
and July 2020, using electronic platforms such as WhatsApp
and Facebook for access to the questionnaire by interested
respondents. We opted for web-based survey over physical
questionnaire administration following the existing COVID-19
preventive regulations as of the time of data collection. InNigeria,
COVID-19 prevention guidelines of physical distancing were
advocated and enforced by the NCDC andWHO. The minimum
sample size of 384 was calculated using the Cochran formula
for cross-sectional studies at 95% confidence level and 5% error
margin, and based on an estimated SM prevalence of 52.1%
from a previous study (12). A total of 461 respondents had
participated in the study at 11.59 pm on July 30, which we
considered as adequate for a large population (18). The inclusion
criterion was that a participant must be resident in Nigeria.
Been a web-based data collection study, participants is therefore
limited to those who are literate, have access to smart phone
and internet.
Questionnaire Design
The questionnaire was divided into two sections- demographics
section, and another section containing questions on knowledge,
causes, and practice (KCP) of SM. The demographic variables
included age, gender, marital status, religion, education level,
occupation, and average income per month. The knowledge
questions had three items (K1-K3), while the causes and practice
of SM questions contained seven (C1-C7) and eleven (P1-P11)
items, respectively. A sample of the questionnaire is available in
the Supplementary Material.
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Data Collection
Data were collected using questionnaires administered
electronically between June 1, 2020 and July 30, 2020. The
questionnaire was developed and validated by the authors, based
on a previous study (19). Though, Cronbach’s Alpha (CA) was
calculated as 0.76, suggesting better validity and reliability of the
questionnaire. Due to COVID-19 safety guidelines, the study
utilizes convenience sampling method and authors used their
contacts and media platform to reach the respondents. Through
these contacts questionnaire was shared among the populations
that have access to smart phones in cities and village where there
was availability of internet.
Statistical Analysis
Data were downloaded from the google forms using the comma-
separated values (CSV) option and exported into STATA version
15 (Stata Corp, College Station, TX, USA) which was used for
the statistical analysis. For the purpose of analysis, the correct
answer was scored as one, and any other as zero. Thereafter,
the total score was converted to a percentage to create the
two categories: insufficient knowledge (<49%) and sufficient
knowledge (≥50%) (11). The baseline characteristics of the
study participants were analyzed using descriptive statistics. The
frequencies and percentages were used to present the categorical
variables; mean and standard deviation were used to present
continuous variables.
The associations between the practice of SM and the
demographic variables as the explanatory variables were tested
using the Chi-square test. The binary logistic regression model
was used to determine the factors associated with SM practice.
The response was binary: practiced SM vs. did not practice SM
for COVID prevention. We estimated the crude from bivariate
models and adjusted odds ratios (ORs) from multivariable
models, together with their 95% confidence intervals (CI) and
P-values. P-value <0.05 and 95% CI, not including unity, were
considered statistically significant.
RESULTS
Description of Study Participants and Their
Prevalence
A total of 461 respondents participated in the survey with a
mean age of 42.2 years with a standard deviation of 10.7 years.
Among the participants, 57.1% were female, 71.7% were married,
88.7% were employed, 87.8% had attained tertiary education,
95.8% belonged to the Christian religion, and 80.9% hadmonthly
incomes >50,000 Nigerian Naira ($130.00). The proportion
of respondents that had sufficient knowledge about SM was
96.7%. The overall prevalence of SM for perceived treatment or
prevention of COVID-19 was 41% and among respondents aged
<24 years, with below tertiary education, of Islamic religion and
who had insufficient knowledge of the risks of SM, the prevalence
figures were notably higher than 30%. These are summarized in
Table 1.
Causes for Self-Medication for COVID-19
Respondents were asked multiple-response questions on why
they practiced SM. Figure 1 shows the list of reasons that were
TABLE 1 | Characteristics of study participants and prevalence of self-medication.





Female 263 57.1 22.4 0.038*
Male 198 42.9 20.2
Age as at last birthday (years)
<24 25 5.4 36.0 0.258
25–34 78 16.9 20.5
35–44 157 34.1 21.0
45–54 154 33.4 19.5
>55 47 10.2 23.4
Mean ± SD (years) 42.2 ± 10.7
Marital status
Married 327 71.7 21.4 0.862
Not married 129 28.3 20.1
Occupation
Employed 402 88.7 20.2 0.547
Unemployed 51 11.3 21.6
Educational level
Below tertiary 56 12.2 30.6 0.017*
Tertiary 405 87.8 20.3
Religion
Christianity 439 95.8 20.7 0.834
Islam 19 4.2 31.6
Monthly income (NGN)
<10,000 24 5.4 16.7 0.543
10,000–50,000 61 13.7 23.0
>50,000 361 80.9 19.7
Knowledge on self-medication
Insufficient knowledge 15 3..3 60.00 0.021*
Sufficient knowledge 446 96.7 20.2
Total 461 100.0 41.0
*Significant at 5% level of error. 1 USD = 386.84 NGN.
given. As shown in Figure 1, SM for COVID-19 prevention
and/or perceived treatment was mostly caused by fear of
stigmatization or discrimination (79.5%), fear of quarantine or
self-isolation (77.3%), and fear of infection or contact with a
suspected or known COVID-19 case (76.3%). Other reported
reasons were “delay in receiving treatment at health facilities”
(55.6%), “influence of friends to use self-medication to prevent
or treat COVID-19” (55.2%), “television, radio, newspaper,
and social media can influence self-medication for COVID-19”
(54.3%) and “non-availability of drugs for COVID-19 treatment
in the health facilities” (53%).
Self-Medication Practices for the
Treatment and/or Prevention of COVID-19
Table 2 shows the SM, the reasons for SM, and the status of
the person that recommended the medication. Most of the
respondents gave emergency illness (49.1%) as the reason for
SM, other reasons given were delay in getting hospital services
(28.1%), distance to the health facility (23%), the proximity of
Frontiers in Public Health | www.frontiersin.org 3 June 2021 | Volume 9 | Article 606801
Wegbom et al. COVID-19 Self-Medication
FIGURE 1 | Causes of self-medication among the respondents.
TABLE 2 | Self-medication practices.
Questions Frequency Percentage
1) Taking drugs intended to prevent/treat
COVID-19 without prescription by medically
qualified personnel? (n = 461)
189 41.0
2) *Reasons for taking medication without prescription by medically
qualified personnel was due to: (n = 461)
Emergency illness 173 49.1
Distance to the health facility 81 23.0
Proximity of the pharmacy 74 21.0
Health facility charges 54 15.3
No medicine in health facility 68 19.3
Delaying of the hospital services 99 28.1
Others 14 4.0
3) *Prescription of the medication was by: (n = 461)
Medical personnel from health facility 104 35.4




the pharmacy (21%), non-availability of medicine in a health
facility (19.3%) and Health facility charges (15.3%). Table 2 also
revealed that more than half of the respondents prescribed the
medication themselves (53.7%), 35.4% got the prescription from
medical personnel in a health facility, 24.8% got theirs from the
workers in pharmacy, and 16.0% from their friends.
Figure 2 revealed that most of the drugs used for self-
medication in the treatment and prevention of COVID-19
were Vitamin C and Multivitamin (51.8%) and antimalarial
drugs other than Hydroxychloroquine and Chloroquine (47.1%).
Others were Amoxicillin (24.9%), Ciprofloxacin (14.6%), Herbal
products (10.2%), Metronidazole (8.5%), Erythromycin (5.3%),
and Hydroxychloroquine and Chloroquine (3.2%). Figure 3
showed that the majority of the respondents bought their
drugs for self-medication at the pharmacy (73.9%). Other
places of the purchase were patent medicine vendor (23.6%),
hospital (7.6%), hawkers (4.5%). Those who bought the
medication at faith-based outlets and herbalists were of the same
proportion (2.1%).
Factors Associated With Self-Medication
Practices for Perceived COVID-19
Treatment or Prevention
In the bivariate logistic regression model, gender, educational
level, and knowledge about SM were significantly associated with
the practice of SM in the prevention and/or perceived treatment
of COVID-19 at p-value < 0.05. The males were 14% [odds
ratio (OR): 0.86; 95% Confidence Interval (CI): 0.03–0.41] less
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FIGURE 2 | Distribution of Substances used for self-medication.
FIGURE 3 | Source of medicine used for self-medication.
likely to indulge in SM than the females. Those who had tertiary
education were more (OR: 1.60; 95% CI: 1.08–2.29) likely to self-
medicate than those with lower level of education. Furthermore,
those who had sufficient knowledge on SM were less likely
to practice SM compared when compared with those with
insufficient knowledge (OR: 0.79; 95% CI: 0.16–0.59) as shown
in Table 3. Whereas, age, marital status, occupation, religion,
and income were not statistically significant. On the other hand,
after controlling for other variables in the multivariable logistic
regression model, the odds of SM practice were generally lower
among males (OR: 0.79; 95% CI: 0.07–0.54) compared with
the females and among those with sufficient knowledge of SM
(OR: 0.64; 95% CI: 0.19–0.77) than those that have insufficient
knowledge about SM.
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TABLE 3 | Crude and adjusted factors associated with self-medication.
Variable Crude estimate Adjusted estimate
Overall COR (95% CI) P-value AOR (95% CI) P-value
Gender
Female 1.00 1.00
Male 0.86 (0.03–0.41) 0.038* 0.79(0.07–0.54) 0.023*
Age as at last birthday
<24 1.00 1.00
25–34 2.69(0.85–8.48) 0.091 2.10(0.50–8.89) 0.311
35–44 1.23(0.45–3.37) 0.689 0.93(0.23–3.77) 0.916
45–54 1.42(0.51–3.92) 0.497 0.98(0.24–4.07) 0.988
>55 2.01(0.53–7.53) 0.638 1.45(0.27–7.66) 0.663
Marital status
Married 1.00 1.00
Not married 1.05(0.60–1.81) 0.862 0.97(0.51–1.83) 0.924
Occupation
Employed 1.00 1.00
Unemployed 1.30(0.55–3.08) 0.553 1.81(0.48–6.72) 0.376
Educational level
Below tertiary 1.00 1.00
Tertiary 1.60(1.08–2.29) 0.017* 1.71(0.30–1.69) 0.443
Religion
Christianity 1.00 1.00
Islam 0.89(0.31–2.53) 0.833 0.76(0.23–2.49) 0.656
Monthly income (NGN)
<10,000 1.00 1.00
10,000–50,000 0.56(0.16–1.93) 0.360 0.84 (0.18–3.86) 0.825







0.79 (0.16–0.59) 0.021* 0.64 (0.19–0.77) 0.042*
*Significant at 5% level of error.
DISCUSSION
This study aimed to estimate the knowledge, causes, prevalence,
and determinants of self-medication practices for the prevention
and/or treatment of COVID-19 in Nigeria. Though self-
medication for minor illnesses is approved WHO, but with
caution (7), our study investigated the use of self-medication for
perceived COVID-19 prevention/or treatment. To the best of
our knowledge, this study is novel in Nigeria as far as COVID-
19 is concerned, although there are previous studies on self-
medication practices other than COVID-19 both in Nigeria
and elsewhere.
The estimation and quantification of the knowledge level,
prevalence, and the reasons for self-medication practices for
COVID-19 perceived treatment or prevention, as well as
associated determinants, are of great importance due to their
consequent effect on the fight to control and mitigate the
disease. Our study has demonstrated sufficient knowledge for
self-medication among respondents, namely as high as 96.7%.
This finding is similar to previous studies in Nigeria (11, 12) and
overseas (8, 19), where a sizeable proportion of the respondents
had sufficient knowledge of self-medication. From our study,
the prevalence of self-medication for COVID-19 treatment or
prevention was 41%. This finding was comparably higher than
what was earlier reported in Togo (20). We also observed a
prevalence of above 30% among respondents <24 years, that
attained below tertiary education, of Islamic faith, and with
insufficient knowledge of self-medication. Our findings were
similar to previous studies on self-medication (21–24). The
reason for the high prevalence was attributed to the ease of access
to OTC drugs, the presence of unregistered medicine stores, and
pharmacies (14, 15).
Our study identified the reasons for self-medication for
perceived treatment or prevention of COVID-19 in Nigeria,
as fear of stigmatization or discrimination, fear of being
quarantined or self-isolation, fear of infection, or contact with a
suspected or known case of COVID-19. The list of reasons also
included a delay in receiving treatment at the health facilities,
influence of friends, unavailability of drugs for the treatment,
and influence of media. The others were emergency illness, delay
in receiving hospital services, distance to the health facility, and
proximity of the pharmacy. We acknowledge the fact that some
of our findings are different from those reported previously by
earlier studies for self-medication, although these were not for
COVID-19. Nevertheless, most of our findings have also been
previously reported elsewhere. For instance, emergency illness
had been reported as a reason for self-medication (19, 25);
others were delay in receiving treatment at health facilities and
hospital services (19, 20, 26), the influence of friends (25, 27),
unavailability of drugs, distance to the health facility, proximity
of the pharmacy to home and charges at a health facility (19, 25),
as well as stigmatization (20) and influence of the media (20, 21).
Our findings indicated that out of those who self-medicated
for the perceived treatment or prevention of COVID-19, more
than half of the participants had prescribed the drugs by
themselves, over one-third got their prescriptions from medical
personnel and some others got theirs either directly from
the pharmacies or through recommendation by friends. These
findings were in line with studies on self-medication in Nigeria
(17), Peru (22), Kenya (23), Dhaka (24), Pakistani (26), Eritrea
(9), Iran (28), and Saudi Arabia (29). As with other studies
(12, 23, 30), ours showed that of all those who self-medicated
in the last 3 months, more than half, only self-medicated once,
while others indulged in self-medication at least once a week. As
our results suggested, the possible reason for this huge difference
between those who self-medicated once and those who did so at
least once a week, might be attributed to either side effects, or the
relief from symptoms of the disease.
The most common drugs used for self-medication in
the perceived treatment or prevention of COVID-19 were
Vitamin C and Multivitamins, as well as antimalaria drugs
other than Hydroxychloroquine/Chloroquine. Others were
Amoxicillin, Ciprofloxacin, Herbal products, Erythromycin,
Metronidazole, and Hydroxychloroquine and Chloroquine. The
possible explanation for the high usage of Vitamin C and
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Multivitamin by the participants might be because Vitamin C
had been reported to have significant potency and efficacy in the
management of COVID-19 (31), as well as the availability of these
products without restriction and control. Furthermore, the claim
of a possible association between COVID-19 and Malaria might
be responsible for the high consumption of antimalaria drugs
among the study participants.
The disaggregation of Hydroxychloroquine and Chloroquine
from other antimalaria drugs was informed by the non-
randomized trial conducted in French which seemed to
suggest a positive outcome in the treatment of COVID-19
patients, particularly those that received Hydroxychloroquine
(600 mg/day) (32), and the claim by the American President,
Donald Trump that he used Hydroxychloroquine to prevent
COVID-19 infection (33). Like other self-medication studies (14,
19–21), our study showed that some of the participants also used
antibiotics, such as Amoxicillin, Ciprofloxacin, Erythromycin,
and Metronidazole either as a perceived treatment or prevention
of COVID-19. In our study, 10.2% of the participants used herbal
products for similar purposes. This could be explained by the
fact that traditional medicines were frequently used in Nigeria
for the treatment of diseases (34, 35), and also because of the
availability and low cost of herbal products in African countries
(20). It is interestingly worthy of note, that the WHO has
welcomed innovations around the world, including traditional
medicines/herbal products in the search for potential treatments
for COVID-19 (6).
Pharmacy and patent medicine vendors were identified as
a significant source of drugs and substances used for self-
medication among our study participants. Our results agreed
with those reported by other studies in Nigeria and across
the globe (9, 12, 14, 23, 30). The explanations might include
the fact that most of the study participants were of high
socioeconomic status in terms of employment, educational
attainment, and monthly income. Another prominent reason
for high pharmacy patronage of self-medication drugs was the
inability of government or relevant authorities to regulate and
control the pharmacy and patent medicine stores, such that
medications were and are still being dispensed and purchased at
these stores without a check (14, 15).
Self-medication for COVID-19 prevention and/or perceived
treatment was significantly associated with gender, educational
attainment, and knowledge level on SM in our study. The odds
of SM among those who had sufficient knowledge were 64%
lesser compared with those with insufficient knowledge. A likely
possibility would be that the knowledgeable members might be
more fearful of the bad adverse reactions associated with self-
medication (25). Our study also indicated that the odds of SM
for the COVID-19 were significantly lower among males by
79% than among females. This result was in agreement with
those reported by some other studies on self-medication practices
(36, 37), but in disagreement with the findings of some other
studies (9, 25).
Study Limitations and Strength
Our findings should be interpreted with caution as the
findings are not generalizable on Nigeria population. We had
used a web-based survey which restricted the respondents to
mostly those that had education and the middle and upper
economic class who could afford an internet-enabled phone
from which data was collected. Therefore, caution must be
exercised while interpreting our findings as it may not be
generalizable on all residents in Nigeria. A study that will
reach out to all segments of the population should therefore
be carried out in Nigeria. However, this is probably the
first study to explore the knowledge, causes, prevalence, and
factors possibly associated with self-medication for perceived
COVID-19 prevention and/or treatment among the Nigerian
population. Another strength of the study lies in the fact that
it showed that various medications were used by participants
in the prevention (mainly vitamin C and multivitamins) and
treatment (antibiotics/antimicrobials) of COVID-19 among the
well-educated Nigerian population.
CONCLUSION
The important finding of the study was the use of different
over-the-counter medications for the prevention and treatment
of perceived COVID-19 by the Nigerian with mainly tertiary
education. Vitamin C, multivitamins, antimalaria, and antibiotic
drugs were the most used medications for the prevention
and treatment for COVID-19 infection because of fear of
stigmatization or discrimination, fear of being quarantined,
fear of contact with an infected person, emergency illness, and
delaying of the hospital services. We suggest that medication
outlets, media and community should be engaged to support the
rational use of medication for the prevention/or treatment of
perceived COVID-19 infection.
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